Canadian radiopharmaceutical firm Draxis Health of Mississauga, ON, has successfully completed its purchase of the remaining shares of Draxis Pharma, a contract manufacturing subsidiary. Draxis bought the shares from SGF Santé, which had held a 32.7% minority interest.
Draxis paid Canadian $13 million ($9.58 million, U.S.) to SGF Santé, and assumed outstanding loans owed by Draxis Pharma of approximately $4.2 million ($3.1 million) to SGF and $2.3 million ($1.7 million) to Investissement Québec, Draxis said.
By AuntMinnie.com staff writersApril 23, 2004
Related Reading
Draxis closes unit share deal, April 22, 2004
DraxImage, Isotope Products ink distribution deal, March 22, 2004
DraxImage gets FDA OK for skeletal imaging kit, March 1, 2004
Draxis Q4 and year-end revenues jump, February 6, 2004
Draxis revenues jump, November 6, 2003
Copyright © 2004 AuntMinnie.com
